Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis A Hesselink

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|February 3, 2015
When a zero mismatch is no longer superiorDennis A Hesselink
Therapeutic Drug Monitoring|September 21, 2022
TDM Is Alive and Kicking!Florian Lemaitre, Dennis A Hesselink
Nature Reviews. Nephrology|December 17, 2014
Renal transplantation in 2014: renal transplantation-reducing risk and improving outcomeDennis A Hesselink, Willem Weimar
Transplantation|June 22, 2022
One Biomarker to Diagnose Them All?Dennis A Hesselink, Karin Boer
Transplantation|June 22, 2016
Belatacept: A Game Changer?Teun Van Gelder, Dennis A Hesselink
Clinical Pharmacology and Therapeutics|October 4, 2005
Genetic and nongenetic determinants of between-patient variability in the pharmacokinetics of mycophenolic acidDennis A Hesselink, Teun van Gelder
Transplant International : Official Journal of the European Society for Organ Transplantation|March 12, 2015
Mycophenolate revisitedTeun van Gelder, Dennis A Hesselink
British Journal of Clinical Pharmacology|December 31, 2024
Therapeutic drug monitoring-Does it really matter?Hans Lennernäs, Jack Cook, Dennis A Hesselink
Asian Biomedicine : Research, Reviews and News|February 23, 2026
A beginner's guide to the clinical approach and key concepts of glomerular disease: a mini reviewSuwasin Udomkarnjananun, Talerngsak Kanjanabuch, Dennis A Hesselink
Therapeutic Drug Monitoring|June 24, 2010
The pharmacogenetics of calcineurin inhibitor-related nephrotoxicityDennis A Hesselink, Rachida Bouamar, Teun van Gelder
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
Transplant International : Official Journal of the European Society for Organ Transplantation|February 3, 2015
When a zero mismatch is no longer superiorDennis A Hesselink
Therapeutic Drug Monitoring|September 21, 2022
TDM Is Alive and Kicking!Florian Lemaitre, Dennis A Hesselink
Nature Reviews. Nephrology|December 17, 2014
Renal transplantation in 2014: renal transplantation-reducing risk and improving outcomeDennis A Hesselink, Willem Weimar
Transplantation|June 22, 2022
One Biomarker to Diagnose Them All?Dennis A Hesselink, Karin Boer
Transplantation|June 22, 2016
Belatacept: A Game Changer?Teun Van Gelder, Dennis A Hesselink
Clinical Pharmacology and Therapeutics|October 4, 2005
Genetic and nongenetic determinants of between-patient variability in the pharmacokinetics of mycophenolic acidDennis A Hesselink, Teun van Gelder
Transplant International : Official Journal of the European Society for Organ Transplantation|March 12, 2015
Mycophenolate revisitedTeun van Gelder, Dennis A Hesselink
British Journal of Clinical Pharmacology|December 31, 2024
Therapeutic drug monitoring-Does it really matter?Hans Lennernäs, Jack Cook, Dennis A Hesselink
Asian Biomedicine : Research, Reviews and News|February 23, 2026
A beginner's guide to the clinical approach and key concepts of glomerular disease: a mini reviewSuwasin Udomkarnjananun, Talerngsak Kanjanabuch, Dennis A Hesselink
Therapeutic Drug Monitoring|June 24, 2010
The pharmacogenetics of calcineurin inhibitor-related nephrotoxicityDennis A Hesselink, Rachida Bouamar, Teun van Gelder
Pageof 25